Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Affective Disorders
Interventions
DRUG

Ziprasidone

Target dosage 120-160mg/day based on tolerance

DRUG

Sertraline

Target dosage 150-200mg/day based on tolerance.

DRUG

Haloperidol

Target dosage 6-8mg/day based on tolerance.

Trial Locations (3)

90033

University of Southern California, Los Angeles

560029

National Institute of Mental Health and Neuroscience, Bangalore

Unknown

Alexandria University, Alexandria

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

National Institute of Mental Health and Neuro Sciences, India

OTHER

lead

Duke University

OTHER